Join
Live feed
·
PRReleasevia Quantisnow
I-MAB logo

I-Mab To Present Positive Updated Givastomig Monotherapy Data at 2025 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference on October 23, 2025

ByQuantisnow·Wall Street's wire, on your screen.
IMAB· I-MAB
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IMAB (I-MAB) and more on Quantisnow.